Royal Bank of Canada’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $893K | Sell |
16,720
-9,882
| -37% | -$528K | ﹤0.01% | 3686 |
|
|
2025
Q1 | $1.08M | Buy |
26,602
+3,263
| +14% | +$132K | ﹤0.01% | 3104 |
|
|
2024
Q4 | $649K | Buy |
23,339
+241
| +1% | +$6.7K | ﹤0.01% | 3452 |
|
|
2024
Q3 | $662K | Buy |
23,098
+222
| +1% | +$6.36K | ﹤0.01% | 3468 |
|
|
2024
Q2 | $537K | Buy |
22,876
+5,410
| +31% | +$127K | ﹤0.01% | 3600 |
|
|
2024
Q1 | $441K | Sell |
17,466
-12,936
| -43% | -$327K | ﹤0.01% | 3658 |
|
|
2023
Q4 | $710K | Buy |
30,402
+11,737
| +63% | +$274K | ﹤0.01% | 3471 |
|
|
2023
Q3 | $944K | Buy |
18,665
+13,815
| +285% | +$699K | ﹤0.01% | 3052 |
|
|
2023
Q2 | $226K | Buy |
4,850
+1,525
| +46% | +$71.1K | ﹤0.01% | 4214 |
|
|
2023
Q1 | $127K | Sell |
3,325
-1,987
| -37% | -$75.9K | ﹤0.01% | 4613 |
|
|
2022
Q4 | $292K | Buy |
5,312
+2,707
| +104% | +$149K | ﹤0.01% | 4103 |
|
|
2022
Q3 | $89K | Buy |
2,605
+235
| +10% | +$8.03K | ﹤0.01% | 4895 |
|
|
2022
Q2 | $22K | Sell |
2,370
-1,423
| -38% | -$13.2K | ﹤0.01% | 5595 |
|
|
2022
Q1 | $53K | Sell |
3,793
-3,830
| -50% | -$53.5K | ﹤0.01% | 5566 |
|
|
2021
Q4 | $161K | Buy |
7,623
+3,258
| +75% | +$68.8K | ﹤0.01% | 5026 |
|
|
2021
Q3 | $97K | Buy |
4,365
+393
| +10% | +$8.73K | ﹤0.01% | 5215 |
|
|
2021
Q2 | $99K | Buy |
3,972
+1,320
| +50% | +$32.9K | ﹤0.01% | 5137 |
|
|
2021
Q1 | $77K | Buy |
2,652
+821
| +45% | +$23.8K | ﹤0.01% | 5137 |
|
|
2020
Q4 | $48K | Buy |
1,831
+740
| +68% | +$19.4K | ﹤0.01% | 5128 |
|
|
2020
Q3 | $34K | Hold |
1,091
| – | – | ﹤0.01% | 5020 |
|
|
2020
Q2 | $27K | Sell |
1,091
-49
| -4% | -$1.21K | ﹤0.01% | 4992 |
|
|
2020
Q1 | $24K | Buy |
1,140
+396
| +53% | +$8.34K | ﹤0.01% | 4960 |
|
|
2019
Q4 | $17K | Buy |
744
+700
| +1,591% | +$16K | ﹤0.01% | 5318 |
|
|
2019
Q3 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 5710 |
|